Massimo Franchini (M Franchini)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 67

Top Topics

Emergency Medical

Coronavirus Disease

Systematic Review

Top Venues

Life (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Daniele Focosi, Arturo Casadevall, Massimo Franchini, Fabrizio Maggi
Sotrovimab: A Review of Its Efficacy against SARS-CoV-2 Variants. Viruses 16 (2) (2024)
Massimo Franchini, Daniele Focosi
Hyperimmune Plasma and Immunoglobulins against COVID-19: A Narrative Review. Life (Basel, Switzerland) 14 (2) (2024)
Daniele Focosi, Arturo Casadevall, Massimo Franchini, Fabrizio Maggi
Sotrovimab: A Review of Its Efficacy against SARS-CoV-2 Variants. Viruses 16 (2) (2024)
Massimo Franchini, Carlo Mengoli, Arturo Casadevall, Daniele Focosi
Exploring Study Design Foibles in Randomized Controlled Trials on Convalescent Plasma in Hospitalized COVID-19 Patients. Life (Basel, Switzerland) 14 (7) (2024)
Massimo Franchini, Daniele Focosi, Mario Cruciani, Michael J Joyner, Liise-Anne Pirofski, Jonathon W Senefeld, Shmuel Shoham, David J Sullivan, Arturo Casadevall
Safety and Efficacy of Convalescent Plasma Combined with Other Pharmaceutical Agents for Treatment of COVID-19 in Hospitalized Patients: A Systematic Review and Meta-Analysis. Diseases (Basel, Switzerland) 12 (3) (2024)
Daniele Focosi, Arturo Casadevall, Massimo Franchini, Fabrizio Maggi
Sotrovimab: A Review of Its Efficacy against SARS-CoV-2 Variants. Viruses 16 (2) (2024)
Massimo Franchini, Daniele Focosi
Hyperimmune Plasma and Immunoglobulins against COVID-19: A Narrative Review. Life (Basel, Switzerland) 14 (2) (2024)
Massimo Franchini, Carlo Mengoli, Arturo Casadevall, Daniele Focosi
Exploring Study Design Foibles in Randomized Controlled Trials on Convalescent Plasma in Hospitalized COVID-19 Patients. Life (Basel, Switzerland) 14 (7) (2024)
Massimo Franchini, Carlo Mengoli, Arturo Casadevall, Daniele Focosi
Exploring Study Design Foibles in Randomized Controlled Trials on Convalescent Plasma in Hospitalized COVID-19 Patients. Life (Basel, Switzerland) 14 (7) (2024)
Daniele Focosi, Arturo Casadevall, Massimo Franchini, Fabrizio Maggi
Sotrovimab: A Review of Its Efficacy against SARS-CoV-2 Variants. Viruses 16 (2) (2024)
Massimo Franchini, Daniele Focosi, Mario Cruciani, Michael J Joyner, Liise-Anne Pirofski, Jonathon W Senefeld, Shmuel Shoham, David J Sullivan, Arturo Casadevall
Safety and Efficacy of Convalescent Plasma Combined with Other Pharmaceutical Agents for Treatment of COVID-19 in Hospitalized Patients: A Systematic Review and Meta-Analysis. Diseases (Basel, Switzerland) 12 (3) (2024)
Massimo Franchini, Daniele Focosi, Mario Cruciani, Michael J Joyner, Liise-Anne Pirofski, Jonathon W Senefeld, Shmuel Shoham, David J Sullivan, Arturo Casadevall
Safety and Efficacy of Convalescent Plasma Combined with Other Pharmaceutical Agents for Treatment of COVID-19 in Hospitalized Patients: A Systematic Review and Meta-Analysis. Diseases (Basel, Switzerland) 12 (3) (2024)
Silvia Meschi, Francesca Colavita, Giulia Matusali, Daniele Focosi, Fabrizio Maggi, Massimo Franchini
Incidentally detected West Nile virus-RNA positive blood donors do not harbor high titers of neutralizing antibodies. Transfusion 64 (8) (2024)
Massimo Franchini, Mario Cruciani, Arturo Casadevall, Michael J Joyner, Jonathon W Senefeld, David J Sullivan, Matteo Zani, Daniele Focosi
Safety of COVID-19 convalescent plasma: A definitive systematic review and meta-analysis of randomized controlled trials. Transfusion 64 (2) (2023)
Massimo Franchini, Arturo Casadevall, Michael J Joyner, Daniele Focosi
WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients? Life (Basel, Switzerland) 13 (1) (2023)
Massimo Franchini, Daniele Focosi
The Role of Convalescent Plasma in COVID-19: A Conclusive Post-Pandemic Review. Life (Basel, Switzerland) 13 (12) (2023)
Massimo Franchini, Mario Cruciani, Arturo Casadevall, Michael J Joyner, Jonathon W Senefeld, David J Sullivan, Matteo Zani, Daniele Focosi
Safety of COVID-19 convalescent plasma: A definitive systematic review and meta-analysis of randomized controlled trials. Transfusion 64 (2) (2023)
Massimo Franchini, Marco Zaffanello, Daniele Focosi
Current factor IX replacement options for hemophilia B and the challenges ahead. Expert opinion on pharmacotherapy (2023)
Massimo Franchini, Mario Cruciani, Arturo Casadevall, Michael J Joyner, Jonathon W Senefeld, David J Sullivan, Matteo Zani, Daniele Focosi
Safety of COVID-19 convalescent plasma: A definitive systematic review and meta-analysis of randomized controlled trials. Transfusion (2023)
Massimo Franchini, Mario Cruciani, Arturo Casadevall, Michael J Joyner, Jonathon W Senefeld, David J Sullivan, Matteo Zani, Daniele Focosi
Safety of COVID-19 convalescent plasma: A definitive systematic review and meta-analysis of randomized controlled trials. Transfusion 64 (2) (2023)
Massimo Franchini, Mario Cruciani, Arturo Casadevall, Michael J Joyner, Jonathon W Senefeld, David J Sullivan, Matteo Zani, Daniele Focosi
Safety of COVID-19 convalescent plasma: A definitive systematic review and meta-analysis of randomized controlled trials. Transfusion 64 (2) (2023)
Daniele Focosi, Silvia Meschi, Sabrina Coen, Maria Carla Iorio, Massimo Franchini, Maria Lanza, Fabrizio Maggi
Serum anti-Spike immunoglobulin G levels in random blood donors in Italy: High-titre convalescent plasma is easier than ever to procure. Vox sanguinis (2023)
Massimo Franchini, Mario Cruciani, Arturo Casadevall, Michael J Joyner, Jonathon W Senefeld, David J Sullivan, Matteo Zani, Daniele Focosi
Safety of COVID-19 convalescent plasma: A definitive systematic review and meta-analysis of randomized controlled trials. Transfusion (2023)
Massimo Franchini, Mario Cruciani, Arturo Casadevall, Michael J Joyner, Jonathon W Senefeld, David J Sullivan, Matteo Zani, Daniele Focosi
Safety of COVID-19 convalescent plasma: A definitive systematic review and meta-analysis of randomized controlled trials. Transfusion 64 (2) (2023)
Massimo Franchini, Mario Cruciani, Arturo Casadevall, Michael J Joyner, Jonathon W Senefeld, David J Sullivan, Matteo Zani, Daniele Focosi
Safety of COVID-19 convalescent plasma: A definitive systematic review and meta-analysis of randomized controlled trials. Transfusion 64 (2) (2023)
Massimo Franchini, Arturo Casadevall, Michael J Joyner, Daniele Focosi
WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients? Life (Basel, Switzerland) 13 (1) (2023)
Massimo Franchini, Daniele Focosi
The Role of Convalescent Plasma in COVID-19: A Conclusive Post-Pandemic Review. Life (Basel, Switzerland) 13 (12) (2023)
Massimo Franchini, Arturo Casadevall, Michael J Joyner, Daniele Focosi
WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients? Life (Basel, Switzerland) 13 (1) (2023)
Massimo Franchini, Arturo Casadevall, Michael J Joyner, Daniele Focosi
WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients? Life (Basel, Switzerland) 13 (1) (2023)
Massimo Franchini, Mario Cruciani, Arturo Casadevall, Michael J Joyner, Jonathon W Senefeld, David J Sullivan, Matteo Zani, Daniele Focosi
Safety of COVID-19 convalescent plasma: A definitive systematic review and meta-analysis of randomized controlled trials. Transfusion 64 (2) (2023)
Daniele Focosi, Massimo Franchini, Michael J Joyner, Arturo Casadevall
Are convalescent plasma stocks collected during former COVID-19 waves still effective against current SARS-CoV-2 variants? Vox sanguinis 117 (5) (2022)
Massimo Franchini, Claudia Glingani, Giuseppe De Donno, Giuseppe Lucchini, Massimiliano Beccaria, Massimo Amato, Gian Paolo Castelli, Leonardo Bianciardi, Mauro Pagani, Marco Ghirardini, Giuseppe Puma, Barbara Presciuttini, Maria Teresa Costantino, Marilena Frigato, Verena Crosato, Giorgio Tiecco, Alice Mulè, Dorothea Angela Papalia, Francesco Inglese, Fabio Spreafico, Martina Garuti, Antonietta Pecoriello, Giulia Cervi, Graziana Greco, Vanni Galavotti, Tiziana Santini, Angela Berselli, Carlo Montalto, Riccardo Bertoletti, Simona Aurelia Bellometti, Enrico Capuzzo, Dario Benazzi, Gianpaolo Grisolia, Fabio Pajola, Raffaello Stradoni, Matteo Zani, Adriano Verzola, Vito Codeluppi, Silvia Vesentini, Elisa Bellocchio, Marco Candini, Giorgina Ambrosi, Francesca Carandina, Cleante Scarduelli, Albino Reggiani, Salvatore Casari, null On Behalf Of Convalescent Plasma Study Group
Convalescent Plasma for Hospitalized COVID-19 Patients: A Single-Center Experience. Life (Basel, Switzerland) 12 (3) (2022)
Daniele Focosi, Massimo Franchini, Fabrizio Maggi
Modified Hemagglutination Tests for COVID-19 Serology in Resource-Poor Settings: Ready for Prime-Time? Vaccines 10 (3) (2022)
Marco Tuccori, Irma Convertino, Sara Ferraro, Emiliano Cappello, Giulia Valdiserra, Giulia de Luca, Massimo Franchini, Daniele Focosi
Preclinical discovery and development of the casirivimab + imdevimab cocktail for the treatment of novel coronavirus infection: the rise and fall. Expert opinion on drug discovery 17 (6) (2022)
Daniele Focosi, Massimo Franchini, Marco Tuccori, Mario Cruciani
Efficacy of High-Dose Polyclonal Intravenous Immunoglobulin in COVID-19: A Systematic Review. Vaccines 10 (1) (2022)
Daniele Focosi, Massimo Franchini
Antibodies and SARS-CoV-2: New Data on Diagnostics and Therapeutics. Life (Basel, Switzerland) 12 (5) (2022)
Daniele Focosi, Massimo Franchini
SARS-CoV-2 and the safety of blood donations: Time for a brave revision? Transfusion 62 (3) (2022)
Massimo Franchini, Daniele Focosi, Elena Percivalle, Massimiliano Beccaria, Martina Garuti, Omar Arar, Antonietta Pecoriello, Fabio Spreafico, Graziana Greco, Stefano Bertacco, Marco Ghirardini, Tiziana Santini, Michele Schiavulli, Muzzica Stefania, Thaililja Gagliardo, Josè Camilla Sammartino, Alessandro Ferrari, Matteo Zani, Alessia Ballotari, Claudia Glingani, Fausto Baldanti
Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients. Viruses 14 (7) (2022)
Rada M Grubovic Rastvorceva, Sedula Useini, Milena Stevanovic, Ilir Demiri, Elena Petkovic, Massimo Franchini, Daniele Focosi
Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients-An Open-Label Phase II Clinical Trial. Life (Basel, Switzerland) 12 (10) (2022)
Massimo Franchini, Daniele Focosi, Carlo Mengoli, Elena Percivalle, Josè Camilla Sammartino, Alessandro Ferrari, Matteo Zani, Claudia Glingani, Fausto Baldanti
Neutralizing antibody levels against SARS-CoV-2 variants of concern Delta and Omicron in vaccine breakthrough-infected blood donors. Transfusion 62 (6) (2022)
Daniele Focosi, Massimo Franchini
Home and Out-of-Hospital Therapy with COVID-19 Convalescent Plasma in Europe. Life (Basel, Switzerland) 12 (11) (2022)
Daniele Focosi, Massimo Franchini, Arturo Casadevall
On the Need to Determine the Contribution of Anti-Nucleocapsid Antibodies as Potential Contributors to COVID-19 Convalescent Plasma Efficacy. Viruses 14 (11) (2022)
Daniele Focosi, Massimo Franchini
What a Transfusion Physician Should Know about Monkeypox Virus: Barriers to and Risks for Transmission, and Possible Mitigation Strategies. Diagnostics (Basel, Switzerland) 12 (9) (2022)
David J Sullivan, Massimo Franchini, Michael J Joyner, Arturo Casadevall, Daniele Focosi
Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources. Nature communications 13 (1) (2022)
David J Sullivan, Daniele Focosi, Daniel F Hanley, Massimo Franchini, Jiangda Ou, Arturo Casadevall, Nigel S Paneth
Effective antiviral regimens to reduce COVID-19 hospitalizations: a systematic comparison of randomized controlled trials. medRxiv : the preprint server for health sciences (2022)
Marco Zaffanello, Massimo Franchini, Giorgio Piacentini
Pediatric Sleep-Disordered Breathing and Long-Term Complications: Clinical and Health Implications. Journal of clinical medicine 11 (17) (2022)
Mario Piergiulio Pezzo, Antonella Tufano, Massimo Franchini
Role of New Potential Biomarkers in the Risk of Thromboembolism in Atrial Fibrillation. Journal of clinical medicine 11 (4) (2022)
Antonio Coppola, Massimo Franchini, Giovanni Luigi Pappagallo, Alessandra Borchiellini, Raimondo De Cristofaro, Angelo Claudio Molinari, Rita Carlotta Santoro, Cristina Santoro, Annarita Tagliaferri
Current Choices and Management of Treatment in Persons with Severe Hemophilia A without Inhibitors: A Mini-Delphi Consensus. Journal of clinical medicine 11 (3) (2022)
Daniele Focosi, Massimo Franchini
COVID-19 convalescent plasma therapy: hit fast, hit hard! Vox sanguinis 116 (9) (2021)
Massimo Franchini, Fabiana Corsini, Daniele Focosi, Mario Cruciani
Safety and Efficacy of Convalescent Plasma in COVID-19: An Overview of Systematic Reviews. Diagnostics (Basel, Switzerland) 11 (9) (2021)
Daniele Focosi, Massimo Franchini, Liise-Anne Pirofski, Thierry Burnouf, DeLisa Fairweather, Michael J Joyner, Arturo Casadevall
COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors. Viruses 13 (8) (2021)
Daniele Focosi, Massimo Franchini
Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations. Expert review of vaccines (2021)
Mario Cruciani, Giulio Bongiovanni, Massimo Franchini
High-titer convalescent plasma therapy for coronavirus disease 2019 and mortality. Transfusion 61 (6) (2021)
Massimo Franchini, Marco Zaffanello, Pier Mannuccio Mannucci
Bleeding Disorders in Primary Fibrinolysis. International journal of molecular sciences 22 (13) (2021)
Massimo Franchini, Federico Prefumo, Gianpaolo Grisolia, Valentino Bergamini, Claudia Glingani, Marlene Pisello, Francesca Presti, Marco Zaffanello
Convalescent Plasma for Pregnant Women with COVID-19: A Systematic Literature Review. Viruses 13 (7) (2021)
Daniele Focosi, Fabrizio Maggi, Massimo Franchini, Scott A McConnell, Arturo Casadevall
Analysis of Immune Escape Variants from Antibody-Based Therapeutics against COVID-19: A Systematic Review. International journal of molecular sciences 23 (1) (2021)
Massimo Franchini, Giancarlo Maria Liumbruno, Giorgio Piacentini, Claudia Glingani, Marco Zaffanello
The Three Pillars of COVID-19 Convalescent Plasma Therapy. Life (Basel, Switzerland) 11 (4) (2021)
Massimo Franchini, Giuseppe Marano, Claudio Velati, Ilaria Pati, Simonetta Pupella, Giancarlo Maria Liumbruno
Regarding International Forum on Hospital Transfusion Services' Response to COVID-19. Vox sanguinis 115 (8) (2020)
Mario Cruciani, Massimo Franchini, Carlo Mengoli, Giuseppe Marano, Ilaria Pati, Francesca Masiello, Eva Veropalumbo, Simonetta Pupella, Stefania Vaglio, Vanessa Agostini, Giancarlo Maria Liumbruno
The use of whole blood in traumatic bleeding: a systematic review. Internal and emergency medicine 16 (1) (2020)
Antonio Coppola, Giancarlo Castaman, Rita Carlotta Santoro, Maria Elisa Mancuso, Massimo Franchini, Renato Marino, Gianna Franca Rivolta, Cristina Santoro, Ezio Zanon, Laura Sciacovelli, Salvatore Manca, Riccardo Lubrano, Maria Golato, Armando Tripodi, Angiola Rocino, null null
Management of patients with severe haemophilia a without inhibitors on prophylaxis with emicizumab: AICE recommendations with focus on emergency in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET. Haemophilia : the official journal of the World Federation of Hemophilia 26 (6) (2020)
Claudia Del Fante, Massimo Franchini, Fausto Baldanti, Elena Percivalle, Claudia Glingani, Giuseppe Marano, Carlo Mengoli, Cristina Mortellaro, Gianluca Viarengo, Cesare Perotti, Giancarlo Maria Liumbruno
A retrospective study assessing the characteristics of COVID-19 convalescent plasma donors and donations. Transfusion 61 (3) (2020)
Massimo Franchini, Albert Farrugia, Claudio Velati, Alessandro Zanetti, Luisa Romanò, Giuliano Grazzini, Nadia Lopez, Ilaria Pati, Giuseppe Marano, Simonetta Pupella, Giancarlo Maria Liumbruno
The impact of the SARS-CoV-2 outbreak on the safety and availability of blood transfusions in Italy. Vox sanguinis 115 (8) (2020)
Massimo Franchini, Claudia Glingani, Claudia Del Fante, Martina Capuzzo, Vincenza Di Stasi, Giulia Rastrelli, Linda Vignozzi, Giuseppe De Donno, Cesare Perotti
The protective effect of O blood type against SARS-CoV-2 infection. Vox sanguinis 116 (2) (2020)
Massimo Franchini, Claudia Glingani, Giuseppe De Donno, Salvatore Casari, Beatrice Caruso, Isabella Terenziani, Cesare Perotti, Claudia Del Fante, Filippo Sartori, Mauro Pagani
The first case of acquired hemophilia A associated with SARS-CoV-2 infection. American journal of hematology 95 (8) (2020)
Massimo Franchini, Giuseppe Marano, Claudio Velati, Ilaria Pati, Simonetta Pupella, Giancarlo Maria Liumbruno
Operational protocol for donation of anti-COVID-19 convalescent plasma in Italy. Vox sanguinis 116 (1) (2020)
Massimo Franchini, C Mengoli, G Marano, S Pupella, Pier Mannuccio Mannucci, G M Liumbruno
The importance of ABO blood group in pharmacokinetic studies in haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia 24 (3) (2018)
Annarita Tagliaferri, Massimo Franchini, Gianna F Rivolta, Stefania Farace, Gabriele Quintavalle, Antonio Coppola, null null
Pain assessment and management in haemophilia: A survey among Italian patients and specialist physicians. Haemophilia : the official journal of the World Federation of Hemophilia 24 (5) (2018)